Dreams take us to an alternate reality while we’re fast asleep. A new study led by Northwestern researchers shows that a person in the midst of a vivid dream can perceive incoming questions and provide answers to them.
Northwestern researchers discovered that an experimental drug called NU-9 shows promise as an early intervention for Alzheimer’s disease. Invented by chemistry professor Richard Silverman, NU-9 is a small molecule compound that is currently being tested as a treatment for ALS.
Accurate diagnosis is the foundation of effective medical care, yet hundreds of thousands of Americans are harmed each year by misdiagnosis. Improving outcomes will require not just better technology but a renewed emphasis on bedside skills, observation and human connection.
Never miss a Northwestern Magazine story:
Get the latest stories from the magazine in your inbox six times per year.
Reader Responses
No one has commented on this page yet.
Submit a Response